Dr Reddy's and Nestle Health Expand Obesity Nutrition Care

Dr Reddy’s and Nestlé Health Science have strengthened their presence in India’s growing obesity nutrition care market with the launch of Celevida GLP+, a nutrition supplement designed for people using GLP-1 and GIP-based therapies for obesity and type 2 diabetes.

The new product targets patients taking advanced weight management and diabetes medications, including therapies similar to semaglutide treatments.

Celevida GLP+ is aimed at supporting muscle health, improving nutritional intake, and helping patients maintain metabolic balance during weight-loss treatment.

The launch comes at a time when India is witnessing rising demand for obesity care and metabolic health solutions. With more patients adopting GLP-1-based therapies, healthcare companies are now expanding beyond medicines and focusing on nutrition support linked to long-term treatment outcomes.

Also Read: Transforming API & Pharma Manufacturing with Next-Gen EHS Technologies

According to the companies, the supplement has been developed to address nutritional gaps that may emerge during obesity and diabetes treatment. The product also supports protein intake and muscle preservation, which are considered important during rapid weight loss.

"GLP-1 therapies represent a significant advancement in diabetes and obesity management. However, a clear unmet need remains in supporting patients beyond pharmacological treatment, particularly in addressing nutrition gaps and preserving muscle health during therapy," Dr Reddy's Laboratories CEO, Global Generics and Dr Reddy's and Nestle Health Science Ltd Director, MV Ramana said.

The latest move further strengthens the partnership between Dr Reddy’s and Nestlé Health Science in the fast-growing obesity nutrition care segment. The companies are focusing on building a broader portfolio around metabolic health, preventive nutrition, and chronic disease management in India.

Industry experts expect the obesity treatment market to expand significantly over the next few years as newer therapies become more accessible. This has opened opportunities for pharmaceutical and nutrition companies to create integrated healthcare solutions that combine medication with specialized nutrition products.

Through this launch, Dr Reddy’s and Nestlé Health Science are aiming to capture growing demand from patients seeking comprehensive support for diabetes and obesity management.